A new trading day began on Tuesday, with Tandem Diabetes Care Inc (NASDAQ: TNDM) stock price down -3.98% from the previous day of trading, before settling in for the closing price of $43.50. TNDM’s price has ranged from $13.82 to $53.69 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 36.59%. Meanwhile, its annual earnings per share averaged 49.80%. With a float of $64.94 million, this company’s outstanding shares have now reached $65.55 million.
Let’s determine the extent of company efficiency that accounts for 2400 employees. In terms of profitability, gross margin is 49.06%, operating margin of -17.47%, and the pretax margin is -16.5%.
Tandem Diabetes Care Inc (TNDM) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Tandem Diabetes Care Inc is 0.80%, while institutional ownership is 113.73%. The most recent insider transaction that took place on May 30 ’24, was worth 258,400. In this transaction Director of this company sold 5,000 shares at a rate of $51.68, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 27 ’23, when Company’s Director bought 5,000 for $18.96, making the entire transaction worth $94,778. This insider now owns 19,962 shares in total.
Tandem Diabetes Care Inc (TNDM) Earnings and Forecasts
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.38 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 49.80% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 38.80% during the next five years compared to -6.11% drop over the previous five years of trading.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Trading Performance Indicators
Here are Tandem Diabetes Care Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.09, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -1.18 in one year’s time.
Technical Analysis of Tandem Diabetes Care Inc (TNDM)
Looking closely at Tandem Diabetes Care Inc (NASDAQ: TNDM), its last 5-days average volume was 0.92 million, which is a drop from its year-to-date volume of 1.68 million. As of the previous 9 days, the stock’s Stochastic %D was 34.32%. Additionally, its Average True Range was 2.56.
During the past 100 days, Tandem Diabetes Care Inc’s (TNDM) raw stochastic average was set at 49.43%, which indicates a significant increase from 16.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 55.31% in the past 14 days, which was lower than the 70.86% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $41.86, while its 200-day Moving Average is $34.45. However, in the short run, Tandem Diabetes Care Inc’s stock first resistance to watch stands at $42.96. Second resistance stands at $44.14. The third major resistance level sits at $44.87. If the price goes on to break the first support level at $41.05, it is likely to go to the next support level at $40.32. Should the price break the second support level, the third support level stands at $39.14.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Key Stats
With a market capitalization of 2.73 billion, the company has a total of 64,590K Shares Outstanding. Currently, annual sales are 747,720 K while annual income is -222,610 K. The company’s previous quarter sales were 221,910 K while its latest quarter income was -30,810 K.
